Resmed (RMD) Finished Goods (2010 - 2026)

Resmed's Finished Goods history runs 17 years deep, the most recent figure standing at $559.0 million for Q1 2026.

• Quarterly Finished Goods rose 8.25% year-over-year to $559.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $559.0 million (up 8.25% YoY) and the FY2025 annual result came in at $557.9 million, up 20.24% from the prior year.
• Finished Goods was $559.0 million for Q1 2026 at Resmed, up from $546.3 million in the prior quarter.
• Across five years, Finished Goods topped out at $580.5 million in Q3 2025 and bottomed at $320.1 million in Q1 2022.
• A 5-year average of $497.3 million and a median of $522.5 million in 2022 frame the typical range for Finished Goods.
• Annual changes were most pronounced in 2022 — Finished Goods soared 96.76% — and 2024, when it decreased 21.89%.
• Resmed's Finished Goods stood at $522.5 million in 2022, then retreated by 11.38% to $463.0 million in 2023, then rose by 11.16% to $514.7 million in 2024, then rose by 6.14% to $546.3 million in 2025, then gained by 2.31% to $559.0 million in 2026.
• Business Quant data shows RMD's Finished Goods at $559.0 million in Q1 2026, $546.3 million in Q4 2025, and $580.5 million in Q3 2025.